CELG News 86.62 06/27/2014 04:33:47 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 86.62 $CELG

Final Glance: Biotechnology companies
AP - Thu Jun 26, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

CORRECTING and REPLACING Celgene Corporation Mourns the Passing of Board of Director Member, Rodman L. Drake
Business Wire - Thu Jun 26, 1:28PM CDT
Third paragraph, second sentence has been deleted because of redundancy.

Midday Glance: Biotechnology companies
AP - Thu Jun 26, 12:21PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

Early Glance: Biotechnology companies
AP - Thu Jun 26, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:

Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before
ACCESSWIRE - Thu Jun 26, 8:37AM CDT
WHITEFISH, MT / June 26, 2014 / Probably the most explosive field in biotechnology right now is that of immuno-oncology. The field is predicated on the concept that the body's immune system can be augmented or taught to modulate cancer without the use of toxic chemotherapy agents and radiation, the standard of care today worldwide. A few years ago, the immuno-oncology research was relatively non-existent, but now it's one of the hottest around with some big pharmas making it a primary directive. Last year, Merck & Co. (NYSE: MRK) brought back Roger Perlmutter, a man with an extensive background in immunology, for a second tour with the company, this time as EVP and President of Merck Research Laboratories, to shepherd a new path for Merck focused on oncology at the research level with an emphasis on immuno-oncology. Last week, Merck enlisted MorphoSys AG in a partnership to develop therapeutic antibodies against immune checkpoints. The antibody experts at MorphoSys are in high demand, inking development agreements with Celgene (NASDAQ: CELG), GlaxoSmithKline (NYSE: GSK), Novartis (NYSE: NVS) and more to develop antibodies to support the human immune system against cancer.

Celgene Corporation Mourns the Passing of Board of Director Member, Rodman L. Drake
Business Wire - Thu Jun 26, 7:30AM CDT
It is with great sadness that Celgene Corporation (NASDAQ:CELG) announces the death of Rodman L. Drake, a member of its Board of Directors since 2006.

'Fast Money' Recap: A Mixed Bag for Housing
at The Street - Wed Jun 25, 4:00AM CDT
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off.

Celgene, Chipotle, Keurig Remain In Buying Range
at Investor's Business Daily - Mon Jun 23, 6:52PM CDT
This week's Big Cap 20 list showed a few changes from last week, as Apple (AAPL), Encana (ECA) and Magna International (MGA) fell out and were replaced by Celgene (CELG), Spectra Energy (SE) and Southwest Airlines (LUV) . Energy plays still dominate...

Stocks Poised For Soft Start; Micros Systems Surges Premarket
at Investor's Business Daily - Mon Jun 23, 7:56AM CDT
The stock market today appeared poised for a mildly lower start despite upbeat Chinese factory data and a round of deal news. Nasdaq 100 futures fell 2 points vs. fair value, while S&P 500 futures edged down less than 1 point. Dow futures lost 12...

Celgene Sees Better Results For Psoriatic Arthritis
at Investor's Business Daily - Fri Jun 20, 5:12PM CDT
When a large biotechnology company has a wonder drug, it makes sense to see if the product can treat multiple diseases. Celgene (CELG) has done well in this regard. In January, Celgene's key drug Abraxane won approval in Europe for use in combination...

Stocks Hold Slim Gains; Celgene, Salix Rally
at Investor's Business Daily - Fri Jun 20, 2:02PM CDT
The major stock indexes continued to trade modestly higher late Friday and were on pace to end the week with gains of more than 1%. The Dow Jones industrial average rose 0.2%. The broader Nasdaq and the S&P 500 edged up 0.1% each. Amid quadruple...

Celgene (CELG) Approaches New Upside Target of $171.95
Comtex SmarTrend(R) - Fri Jun 20, 12:28PM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $166.67 today and has reached the first level of resistance at $170.13. Investors may be interested in a cross of the next upside pivot targets of $171.95 and $177.23.

Celgene Rises on Yet Another Stock Split - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 10:30AM CDT
Shares of Gelgene (CELG) gained following the approval of a stock split.

Shares of CELG Up 12.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 20, 9:33AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $147.87. In approximately 2 months, Celgene has returned 12.94% as of today's recent price of $167.00.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 173

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Fall Pest Risks Linger as Mild Weather Extends Threat

Updated Category News Views 0

A cold snap is not a magic off switch for mosquitoes, ticks, or rodents, and that is the sober point behind the National Pest Management Association's fall and winter 2026 Public Health Pest Index. The group is flagging conditions, not predicting that every household in a named city will face an infestation or illness. Still, mild temperatures, rain, flooding, and plenty...

Continue Reading
Volta M100 Puts Flexibility at Pad Printing's Center

Updated Category News Views 43

A tabletop printer rarely earns a second glance, but the Volta M100 is making a sensible argument: small manufacturers do not need another rigid box that becomes obsolete the minute a job changes. Boston Industrial Solutions has introduced the Volta M100 as a pad-printing machine built around adjustability, operator convenience, and software that can be upgraded as...

Continue Reading
Broadridge Brings Boyman In to Sharpen Its Market Story

Updated Category News Views 44

Financial plumbing rarely gets applause, which is precisely why Broadridge needs somebody who can explain its value without turning the pitch into alphabet soup. Lauren Boyman arrives as chief marketing and communications officer on November 23, taking charge of global marketing, corporate communications, product positioning, digital strategy, lead generation and thought...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 44

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
UN Integrity Accelerator Targets Corporate Corruption

Updated Category News Views 84

Corruption rarely arrives wearing a villain costume; it shows up as a rushed payment, a friendly intermediary, or a contract nobody wants examined too closely. That is why the United Nations Global Compact's new Business Integrity Accelerator deserves a sober look. Launched November 18, 2026, the programme is not a magic shield, and nobody should sell it as one. But it...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 0

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Humanoid Robots Need Results Before 2035 Hype Peaks

Updated Category News Views 178

A robot climbing stairs is neat; a robot finishing Tuesday’s shift is the investment case. The latest humanoid robotics forecast puts the global market at $3.07 billion in 2026, up from $2.26 billion in 2025, and projects $47.49 billion by 2035. That is a 35.59% compound annual growth rate, the kind of number that makes investors sit up straight. It also demands a...

Continue Reading
Panama City Beach Rentals: Rules Before the Ocean View

Updated Category News Views 0

A postcard-perfect balcony can hide a remarkably expensive rulebook. That is the unglamorous message in Angie Outlaw’s discussion of vacation-property buying in Panama City Beach: the view may sell the unit, but zoning, association documents, insurance and lender terms determine whether the purchase behaves anything like the income-producing asset a buyer pictured. I...

Continue Reading
Novo and nference Push Whole-Body Data Into Research

Updated Category News Views 26

Cardiometabolic medicine has spent too long staring at single numbers while the rest of the body keeps waving its arms. Novo Nordisk’s newly announced collaboration with nference is an attempt to widen that lens, combining Novo’s clinical-trial research with nference’s AI technology and federated healthcare data network. The target is not small: obesity, diabetes,...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Crypto Volatility and the REX Osprey XRP ETF

Updated Category News Views 134

Cryptocurrency Market Overview and Recent Trends Up until October, the cryptocurrency market was experiencing significant growth, with a total capitalization reaching approximately $4.28 trillion. This surge was driven by abundant liquidity and a heightened risk appetite among investors. However, the capital markets can be unpredictable, leading to a swift and adverse...

Continue Reading
Intelligent Bio Inks Global Deal to Expand Drug Testing Solutions

Updated Category News Views 126

Intelligent Bio Solutions Launches Global Distribution Pact Intelligent Bio Solutions Inc. (NASDAQ: INBS) has recently announced an exciting global distribution partnership with SMARTOX. This collaboration aims to introduce their innovative SmarTest Patch, a cutting-edge product designed for drug detection, to international markets beyond the U.S. and Canada, marking a...

Continue Reading
Discover the Long-Term Growth of American Financial Group AFG Stock

Updated Category News Views 148

The Remarkable Journey of American Financial Group (AFG) American Financial Group (AFG) has significantly outperformed the market over the past twenty years, showing an annualized return of 9.37%, which surpasses the market by 1.29%. With a market capitalization standing at an impressive $10.39 billion, AFG is a noteworthy player in the financial sector. Investment...

Continue Reading
Current Sentiment Analysis: Canaan Inc's Short Interest Insights

Updated Category News Views 352

Canaan Inc's Current Short Interest Overview Canaan Inc (NYSE: CAN) is witnessing changes in its stock sentiment, particularly regarding its short interest. Recent reports indicate that the short interest, expressed as a percentage of the float, has dropped by 8.14%. Currently, 36.17 million shares are sold short, representing 8.58% of the total shares available for...

Continue Reading
CalExitNow Push for CA GOP Ban & Sovereignty Talks

Updated Category News Views 296

California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...

Continue Reading